T2 Biosystems PE Ratio 2013-2024 | TTOO

Current and historical p/e ratio for T2 Biosystems (TTOO) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. T2 Biosystems PE ratio as of July 11, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

T2 Biosystems PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-07-11 4.97 0.00
2024-03-31 3.00 $-14.11 0.00
2023-12-31 6.28 $-143.45 0.00
2023-09-30 22.09 $-143.45 0.00
2023-06-30 7.06 $-435.00 0.00
2023-03-31 46.00 $-927.00 0.00
2022-12-31 142.00 $-1,295.00 0.00
2022-09-30 565.00 $-1,645.00 0.00
2022-06-30 807.50 $-1,750.00 0.00
2022-03-31 2620.50 $-1,650.00 0.00
2021-12-31 2581.00 $-1,500.00 0.00
2021-09-30 4576.00 $-1,500.00 0.00
2021-06-30 5950.00 $-1,500.00 0.00
2021-03-31 8100.00 $-1,550.00 0.00
2020-12-31 6200.00 $-2,300.00 0.00
2020-09-30 6800.00 $-3,450.00 0.00
2020-06-30 6350.00 $-4,600.00 0.00
2020-03-31 3247.50 $-5,900.00 0.00
2019-12-31 5850.00 $-6,500.00 0.00
2019-09-30 12500.00 $-6,750.00 0.00
2019-06-30 8400.00 $-6,450.00 0.00
2019-03-31 13150.00 $-6,300.00 0.00
2018-12-31 15050.00 $-6,400.00 0.00
2018-09-30 37250.00 $-4,650.00 0.00
2018-06-30 38700.00 $-5,650.00 0.00
2018-03-31 32450.00 $-6,550.00 0.00
2017-12-31 20600.00 $-7,150.00 0.00
2017-09-30 21000.00 $-9,500.00 0.00
2017-06-30 16050.00 $-9,800.00 0.00
2017-03-31 26300.00 $-10,200.00 0.00
2016-12-31 26300.00 $-10,550.00 0.00
2016-09-30 36200.00 $-11,000.00 0.00
2016-06-30 39450.00 $-11,300.00 0.00
2016-03-31 49300.00 $-11,100.00 0.00
2015-12-31 54700.00 $-11,000.00 0.00
2015-09-30 43800.00 $-10,450.00 0.00
2015-06-30 81150.00 $-11,150.00 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.044B $0.007B
T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $207.154B 25.10
Intuitive Surgical (ISRG) United States $157.309B 94.76
Edwards Lifesciences (EW) United States $55.951B 36.41
DexCom (DXCM) United States $44.803B 67.87
Alcon (ALC) Switzerland $44.645B 31.99
IDEXX Laboratories (IDXX) United States $40.284B 47.22
IQVIA Holdings (IQV) United States $39.982B 23.20
STERIS (STE) Ireland $21.534B 25.16
SONOVA HOLDING (SONVY) Switzerland $18.432B 0.00
Waters (WAT) United States $17.884B 26.28
Hologic (HOLX) United States $17.851B 19.97
Fresenius Medical Care AG KGaA (FMS) Germany $11.643B 13.59
Teleflex (TFX) United States $10.574B 16.46
Sysmex ADR (SSMXY) Japan $10.045B 31.50
Globus Medical (GMED) United States $9.578B 28.08
Penumbra (PEN) United States $7.222B 82.07
Glaukos (GKOS) United States $6.207B 0.00
Masimo (MASI) United States $5.920B 34.04
TransMedics (TMDX) United States $4.741B 449.78
Integer Holdings (ITGR) United States $3.928B 23.74
PROCEPT BioRobotics (PRCT) United States $3.514B 0.00
Inari Medical (NARI) United States $3.095B 0.00
Tandem Diabetes Care (TNDM) United States $2.922B 0.00
LivaNova (LIVN) United Kingdom $2.839B 16.85
Integra LifeSciences Holdings (IART) United States $2.412B 10.52
RxSight (RXST) United States $1.841B 0.00
Veracyte (VCYT) United States $1.725B 0.00
Alphatec Holdings (ATEC) United States $1.533B 0.00
Artivion (AORT) United States $1.109B 106.40
Silk Road Medical (SILK) United States $1.067B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.972B 18.91
OPKO Health (OPK) United States $0.955B 0.00
Pulse Biosciences (PLSE) United States $0.891B 0.00
OrthoPediatrics (KIDS) United States $0.790B 0.00
Paragon 28 (FNA) United States $0.630B 0.00
SiBone (SIBN) United States $0.607B 0.00
IRadimed (IRMD) United States $0.589B 33.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.582B 0.00
Mesa Laboratories (MLAB) United States $0.568B 16.80
Treace Medical Concepts (TMCI) United States $0.507B 0.00
Pacific Biosciences Of California (PACB) United States $0.409B 0.00
Sight Sciences (SGHT) United States $0.374B 0.00
AxoGen (AXGN) United States $0.364B 0.00
Nevro (NVRO) United States $0.324B 0.00
Tactile Systems Technology (TCMD) United States $0.280B 9.59
AngioDynamics (ANGO) United States $0.246B 0.00
Semler Scientific (SMLR) United States $0.238B 12.05
Delcath Systems (DCTH) United States $0.222B 0.00
NeuroPace (NPCE) United States $0.213B 0.00
Inogen (INGN) United States $0.212B 0.00
ClearPoint Neuro (CLPT) United States $0.210B 0.00
Accuray (ARAY) United States $0.196B 0.00
908 Devices (MASS) United States $0.184B 0.00
CVRx (CVRX) United States $0.184B 0.00
EDAP TMS S.A (EDAP) France $0.183B 0.00
Atossa Genetics (ATOS) United States $0.161B 0.00
Alpha Tau Medical (DRTS) Israel $0.153B 0.00
KORU Medical Systems (KRMD) United States $0.121B 0.00
Spectral Diagnostics (EDTXF) Canada $0.102B 0.00
Sensus Healthcare (SRTS) United States $0.093B 19.62
EnVVeno Medical (NVNO) United States $0.079B 0.00
Hyperfine (HYPR) United States $0.075B 0.00
Monogram Orthopaedics (MGRM) United States $0.070B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
SEP Acquisition (SEPA) United States $0.060B 0.00
Neuronetics (STIM) United States $0.056B 0.00
Vicarious Surgical (RBOT) United States $0.055B 0.00
LENSAR (LNSR) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
DarioHealth (DRIO) United States $0.040B 0.00
Precision Optics (POCI) United States $0.035B 0.00
ReWalk Robotics (LFWD) Israel $0.034B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Rapid Micro Biosystems (RPID) United States $0.028B 0.00
Accelerate Diagnostics (AXDX) United States $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.023B 0.00
Ekso Bionics Holdings (EKSO) United States $0.021B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.016B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
QT Imaging Holdings (QTI) United States $0.015B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
Autonomix Medical (AMIX) United States $0.011B 0.00
PAVmed (PAVM) United States $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00